Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
-
Published:2022-03
Issue:1
Volume:10
Page:21-27
-
ISSN:2287-8882
-
Container-title:Prostate International
-
language:en
-
Short-container-title:Prostate International
Author:
Hoeh BenediktORCID,
Flammia Rocco,
Hohenhorst Lukas,
Sorce Gabriele,
Chierigo Francesco,
Tian Zhe,
Saad Fred,
Gallucci Michele,
Briganti Alberto,
Terrone Carlo,
Shariat Shahrokh F.,
Graefen Markus,
Tilki Derya,
Kluth Luis A.,
Mandel Philipp,
Chun Felix K.H.,
Karakiewicz Pierre I.
Reference27 articles.
1. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer;Masic;European Urology Oncology,2018
2. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer;Cornford;Eur Urol,2017
3. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology;Mohler;J Natl Compr Cancer Netw,2019
4. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013;Cooperberg;JAMA,2015
5. Can single positive core prostate cancer at biopsy be considered a low-risk disease?;Yamamoto;Int Urol Nephrol,2018
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献